The Scientist

» albedo and genetics & genomics

Most Recent

image: Custom Creatures?

Custom Creatures?

By | January 6, 2015

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

image: Doris Bachtrog: Sex Chromosome Wrangler

Doris Bachtrog: Sex Chromosome Wrangler

By | January 1, 2015

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

image: Mistaken Identities

Mistaken Identities

By | January 1, 2015

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

1 Comment

image: Molecular Hub of Autism?

Molecular Hub of Autism?

By | December 30, 2014

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

image: The Year in Pathogens

The Year in Pathogens

By | December 29, 2014

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

image: Focus on Sex

Focus on Sex

By | December 29, 2014

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

image: New Species Galore

New Species Galore

By | December 27, 2014

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

1 Comment

image: Repurposed Retroviruses

Repurposed Retroviruses

By | December 18, 2014

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

image: Bird Genomes Abound

Bird Genomes Abound

By | December 11, 2014

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

1 Comment

image: Genome Digest

Genome Digest

By | December 5, 2014

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech